Possible roles of transglutaminases in molecular mechanisms responsible for human neurodegenerative diseases

• Main Authors: Nicola Gaetano Gatta, Gaetano Cammarota, Vittorio Gentile
• Format: Article
• Language: English
• Published: AIMS Press 2016-11-01
• Series: AIMS Biophysics
• Subjects: transglutaminases; post-translational modifications of proteins; neurodegeneration; NF-kB; neuroinflammation
• Online Access: http://www.aimspress.com/biophysics/article/1089/fulltext.html

Transglutaminases are a family of Ca²⁺-dependent enzymes which catalyze post-translational modifications of proteins. The main activity of these enzymes is the cross-linking of glutaminyl residues of a protein/peptide substrate to lysyl residues of a protein/peptide co-substrate. In addition to lysyl residues, other second nucleophilic co-substrates may include monoamines or polyamines (to form mono- or bi-substituted/crosslinked adducts) or –OH groups (to form ester linkages). In absence of co-substrates, the nucleophile may be water, resulting in the net deamidation of the glutaminyl residue. Transglutaminase activity has been suggested to be involved in molecular mechanisms responsible for both physiological or pathological processes. In particular, transglutaminase activity has been shown to be responsible for human autoimmune diseases, Celiac Disease is just one of them. Interestingly, neurodegenerative diseases, such as Alzheimer’s Disease, Parkinson’s Disease, supranuclear palsy, Huntington’s Disease and other polyglutamine diseases, are characterized in part by aberrant cerebral transglutaminase activity and by increased cross-linked proteins in affected brains. This review describes the possible molecular mechanisms by which these enzymes could be responsible for such diseases and the possible use of transglutaminase inhibitors for patients with diseases characterized by aberrant transglutaminase activity.